SEED Therapeutics Presents Poster At AACR Annual Meeting 2026
30 Mar 2026 //
GLOBENEWSWIRE
SEED Therapeutics Doses 1st Patient in Phase 1 Trial of ST-01156
09 Jan 2026 //
GLOBENEWSWIRE
FDA Approves IND for SEED`s RBM39 Degrader ST-01156
11 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support